Milky Way Sensor Motion Validation

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorivWatch, LLC

About this trial

A single arm study of 20 adult volunteers to assess the safety and efficacy of the ivWatch sensors when observing non-infiltrated (normal) tissues at common peripheral IV therapy sites.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

18 years of age or older

Healthy individual, verified by an eligible designation on the Health History Form

Disqualifiers

Currently enrolled in another clinical trial

Currently pregnant or trying to become pregnant

Serious and uncontrolled medical condition

Tattoo(s), scarring, or bruising that severely limits vein visualization at a sensor monitoring location

Trial design

Design model

Single group

Treatments tested in this trial

  • ivWatch Model 400

    Device

    The ivWatch Model 400 monitored tissue at common IV sites over a 24 hour period.

Treatment groups

25 Participants
are divided into 1 treatment group
Group A: Non-Infiltrated TissueExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Check IV notification rate per day

The ivWatch Model 400 issues Check IV notifications to communicate the need for a clinician to check an IV site. A red notification suggests an increased likelihood that an IV infiltration may be occurring, with a greater likelihood relative to a yellow notification. This measure describes the average number of red notifications issued by the ivWatch device in a given day when monitoring normal, non-infiltrated tissues. The 95% confidence interval for the red notification rate was calculated using a negative binomial regression model.

Time frame
24 Hours

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: